Quadrature Capital LTD Gossamer Bio, Inc. Transaction History
Quadrature Capital LTD
- $8.45 Trillion
- Q3 2025
A detailed history of Quadrature Capital LTD transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Quadrature Capital LTD holds 79,709 shares of GOSS stock, worth $216,011. This represents 0.0% of its overall portfolio holdings.
Number of Shares
79,709
Previous 95,796
16.79%
Holding current value
$216,011
Previous $117 Million
79.03%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding GOSS
# of Institutions
181Shares Held
163MCall Options Held
8.11MPut Options Held
211K-
Nea Management Company, LLC Timonium, MD18.1MShares$49 Million2.97% of portfolio
-
Octagon Capital Advisors LP New York, NY17.1MShares$46.2 Million14.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$32.5 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$21.8 Million9.24% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA6.13MShares$16.6 Million6.11% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $255M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...